Evidence map›Paper›PMID 30678028›Full record

Trial reportNutrients2019

Pilot Study of Novel Intermittent Fasting Effects on Metabolomic and Trimethylamine

Rachel L Washburn, James E Cox, Joseph B Muhlestein, Heidi T May, John F Carlquist, Viet T Le, Jeffrey L Anderson, Benjamin D Horne

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 3 pooled it
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 3 syntheses or guidelines pooled it, 54 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Intermittent fasting for the prevention of cardiovascular disease.The Cochrane database of systematic reviews · 2021
    Pooled it
  4. Trial
  5. Remodelling of the gut virome after long-term fasting.NPJ biofilms and microbiomes · 2026
    Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. The 5Journal of diabetes · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Rachel L WashburnTexas Tech University Health Sciences Center, Lubbock, TX 79415, USA. rachel.washburn@ttuhsc.edu.
James E CoxDepartment of Biochemistry, University of Utah, Salt Lake City, UT 84132, USA. jcox@cores.utah.edu.
Joseph B MuhlesteinIntermountain Medical Center Heart Institute, Cardiology Division, Department of Internal Medicine, University of Utah, Salt Lake City, UT 84107, USA. jbrent.muhlestein@imail.org.
Heidi T MayIntermountain Medical Center Heart Institute, Salt Lake City, UT 84107, USA. heidi.may@imail.org.ORCID 0000-0002-7524-5905
John F CarlquistIntermountain Medical Center Heart Institute, Cardiology Division, Department of Internal Medicine, University of Utah, Salt Lake City, UT 84107, USA. john.carlquist@imail.org.
Viet T LeIntermountain Medical Center Heart Institute, Rocky Mountain University of Health Professions, Salt Lake City, UT 84107, USA. viet.le@imail.org.ORCID 0000-0001-6659-5332
Jeffrey L AndersonIntermountain Medical Center Heart Institute, Cardiology Division, Department of Internal Medicine, University of Utah, Salt Lake City, UT 84107, USA. jeffreyl.anderson@imail.org.
Benjamin D HorneIntermountain Medical Center Heart Institute, Department of Biomedical Informatics, University of Utah, Salt Lake City, UT 84107, USA. benjamin.horne@imail.org.ORCID 0000-0002-2656-0263
University of Utah · USIntermountain Medical Center · USTexas Tech University · US

Funding

Intermountain Research and Medical Foundation 536
6 · The paper itself

Abstract

Intermittent fasting (IF) has been connected with health benefits such as weight loss, lower risk of coronary artery disease (CAD) and diabetes, increased longevity, and improved quality of life. However, the mechanisms of these IF benefits in humans require further investigation. This study sought to elucidate some of these mechanisms through secondary analyses of the Fasting and ExprEssion of Longevity Genes during fOOD abstinence (FEELGOOD) trial, in which apparently healthy participants were randomized in a Latin square design to a 24-h water-only fast and a 24-h ad libitum fed day. Two pathways were investigated, with trimethylamine

Indexed as

AdultAgedFastingFemaleGas Chromatography-Mass SpectrometryHumansMaleMetabolomeMetabolomicsMethylaminesMiddle AgedPilot ProjectsMethylaminestrimethyloxaminecoronary artery diseasediabetesintermittent energy restrictionintermittent fastingmetabolic analytestrimethylamine N-oxide

Identifiers

PMID30678028
PMCPMC6412259
OpenAlexW2914836926

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.